GI Oncology
From the Journals
Does CRC risk in IBD extend to close family members?
Extra screening for CRC may not be needed for children, siblings, or parents of those with IBD, new study findings suggest.
From the Journals
Colorectal cancer incidence doubled in younger adults
Diagnoses in people younger than 55 years doubled from 1995 to 2019.
From the Journals
Pancreatic cancer incidence increases among young women in U.S.
Additional studies are needed to investigate contributing factors, particularly race and tumor characteristics.
From the Journals
Physician group issues 31 treatment recommendations for early-onset colorectal cancer
There was strong consensus that all individuals younger than 50 should undergo CRC risk stratification and prompt symptom assessment.
From the Journals
Interval FITs could cut colonoscopies in those at above-average risk
Two or more negative tests could suggest less need for colonoscopy at 5 years, especially in those with a family history of colon cancer.
From the Journals
Lifestyle changes may reduce colorectal cancer risk
Decreases in alcohol consumption were significantly associated with a reduction in CRC risk among participants aged 55 years or younger at...
News
Genomic features may explain sex differences in HBV-associated HCC
Therapeutics that favor androgen signaling could improve the efficacy of immune checkpoint inhibitors against HCC.
From the Journals
Liver cancer exacts high financial toll on older adults
In the first year after a hepatocellular carcinoma diagnosis median Medicare payments exceed $65,000.
From the Journals
Chronic hepatitis B infections associated with a range of liver malignancies
Treatment with nucleos(t)ide analogues lowers risk of extrahepatic cancer in patients with hepatitis B infections.
Conference Coverage
Some young CRC patients are missing out on genetic counseling, testing
Genetic counseling and testing of patients under 50 with CRC have improved over the last decade, but about 20% of patients still don’t get...
Conference Coverage
EUS-guided RF ablation doubles survival for unresectable pancreatic cancer
Endoscopic ultrasound–guided radiofrequency ablation of tumors improved overall survival compared with standard of care.